Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity

Background Cancer immunotherapy has taken center stage in cancer treatment. However, the current immunotherapies only benefit a small proportion of patients with cancer, necessitating better understanding of the mechanisms of tumor immune evasion and improved cancer immunotherapy strategies. Regulat...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yuan Li, Yi Zheng, Phuong Nguyen, Ting Wen, Anil G Jegga, Khalid W Kalim, Jun-Qi Yang, Mark Wunderlich, Vishnu Modur, Ashley Kuenzi Davis, Ravinder Verma, Qing Richard Lu, Fukun Guo
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMJ Publishing Group 2022-11-01
Ráidu:	Journal for ImmunoTherapy of Cancer
Liŋkkat:	https://jitc.bmj.com/content/10/11/e004806.full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!